Trillium Therapeutics to Present Clinical Data at the 62nd American Society of Hematology Annual Meeting

NEXT STORY
Ascendis Pharma A/S Announces Participation at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
PREV STORY
AIM Announces Milestone in COVID-19 Treatment and Prevention Efforts with First Patient Dosed in Study Evaluating Ampligen as Part of Combination Treatment for Patients with Cancer and COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hematology Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

author_avatar
NASDAQ Market News

NY-ESO Data Presented at the Connective Tissue Oncology Society (CTOS) Annual Meeting Confirm Potential of Adaptimmune’s SPEAR T-Cell Therapy

PHILADELPHIA and OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...

author_avatar
NASDAQ Market News

Quotient Limited Provides Business Update and Delays Releasing Second Quarter Fiscal 2022 Results

author_avatar
NASDAQ Market News